This may be mainly due to the heterogeneous distribution of angiogenic regulators, such as vascular-endothelial growth factor (VEGF), basic fibroblastic growth factor (bFGF) and angiopoietin [5,13], leading to chaotic tumor blood flow, and hypoxic and acidic tumoral regions [5,14-16]. This evidence concerns the gene FGF2 and neoplasm.